Lung transplantation for cystic fibrosis: Immune system and autoimmunity

Medical Science Monitor

Volumn 7, Issue 6, 2001, Pages 1219-1223

  Šedivá, Anna ^a   Lischke, Robert ^a   Šimonek, Jan ^a   Tkaczyk, Jakub ^a   Vávrová, Vèra ^a   Bartošová, Jana ^a   Pohunek, Petr ^a   Bartůňková, Jiřina ^a   Pafko, Pavel ^a  

^a UNIVERSITY HOSPITAL MOTOL   (Czech Republic)

Author keywords

Autoantibodies; Cystic fibrosis; Lung transplantation

Indexed keywords

CORTICOSTEROID; CYCLOSPORIN A; IMMUNOSUPPRESSIVE AGENT; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NEUTROPHIL CYTOPLASMIC ANTIBODY; PREDNISONE; THYMOCYTE ANTIBODY;

ADULT; ARTICLE; AUTOIMMUNITY; CLINICAL ARTICLE; CYSTIC FIBROSIS; FEMALE; GRAFT REJECTION; HUMAN; IMMUNE SYSTEM; LUNG SURGERY; LUNG TRANSPLANTATION; MALE; ORGAN TRANSPLANTATION;

ADULT; AUTOIMMUNITY; CYSTIC FIBROSIS; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; GRAFT REJECTION; HUMANS; IMMUNITY, CELLULAR; LUNG TRANSPLANTATION; MALE;

EID: 0035215019     PISSN: 12341010     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Cystic fibrosis
2. Comparative genomic sequence analysis of the human and mouse cystic fibrosis transmembrane conductance regulator genes
3. Identification of the cystic fibrosis gene: Genetic analysis
4. Identification of the cystic fibrosis gene: Cloning and characterization of complementary DNA
5. New therapies for cystic fibrosis
6. Lung transplantation for cystic fibrosis
7. Lung transplantation in cystic fibrosis: Consensus conference statement
8. Lung transplantation for cystic fibrosis: An update and practical considerations for referring candidates
9. První plicni transplantace v ceské republice
10. Autoantibodies against bactericidal/permeability increasing protein (BPI) in cystic fibrosis
11. Autoantibodies against bactericidal/permeability increasing protein in patients with cystic fibrosis
12. Anti-neutrophil cytoplasmic antibodies directed against the bactericidal/permeability-increasing protein (BPI) in pediatric cystic fibrosis patients do not recognize N - Terminal regions important for the anti-microbial and lipopolysaccharide-binding activity of BPI
13. Antineutrophil cytoplasmic antibodies in children
14. Outpatient care of the cystic fibrosis patient after lung transplantation
15. Role of the cystic fibrosis transmembrane conductance regulator in innate immunity to Pseudomonas aeruginosa infections
16. Anti-neutrophil cytoplasmic antibodies (ANCA) against bactericidal/permeability-increasing protein (BPI) and cystic fibrosis lung disease
17. Antineutrophil cytoplasmic antibodies (ANCA) in children with cystic fibrosis
18. Revision of the 1990 working formulation for the classification of pulmonary allograft rejection: Lung Rejection Study Group
19. Intracellular survival of Burkholderia cepacia complex isolates in the presence of macrophage cell activation